Research Topics
Genomes and Genes | Neora Yaal-HahoshenSummaryAffiliation: Tel Aviv University Country: Israel Publications
| Collaborators
|
Detail Information
Publications
Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasionAdit Ben-Baruch
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Cell Adh Migr 3:328-33. 2009..This is followed by discussion of open questions that need to be addressed in future research, and of the potential therapeutic implications of the findings that are available to date in this field...
The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and ChemokinesAdit Ben-Baruch
Department Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel
Cancer Microenviron 5:151-64. 2012..The review concludes by discussing the implications of such networks on disease course, and on the future design of therapeutic measures in cancer...
Organ selectivity in metastasis: regulation by chemokines and their receptorsAdit Ben-Baruch
Cancer Biology Research Center, Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Clin Exp Metastasis 25:345-56. 2008....
The multifaceted roles of chemokines in malignancyA Ben-Baruch
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
Cancer Metastasis Rev 25:357-71. 2006..Together, these different chemokine functions establish a net of interactions between the tumor cells and their microenvironment, and partly dictate the fate of the malignancy cascade...
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cellsIdo Nevo
Department of Cell Research and Immunology, The George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
Cancer Lett 273:127-39. 2009..These results led us to hypothesize that the CX3CR1-CX3CL1 axis takes part in bone-marrow metastasis of neuroblastoma...
CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific mannerEfrat Cohen-Hillel
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
Cytokine 33:1-16. 2006..These observations lay the basis for future investigation of the equilibrium between CXCR1 and CXCR2 in cells expressing both receptors together, such as neutrophils, endothelial cells and tumor cells...
CXCL10 promotes invasion-related properties in human colorectal carcinoma cellsAdi Zipin Roitman
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Cancer Res 67:3396-405. 2007..Therefore, care should be taken when considering CXCL10 as a therapeutic antitumor modality for CRC treatment...
Fulvestrant in heavily pretreated metastatic breast cancer: is it still effective as a very advanced line of treatment?Tamar Safra
Department of Oncology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
Isr Med Assoc J 10:339-43. 2008..Over 75% of postmenopausal patients with metastatic breast cancer have hormone receptor-positive tumors. Endocrine therapy, with its more favorable toxicity profile than chemotherapy, is the preferred treatment modality for these patients...
The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell linesLilach Goldberg-Bittman
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel
Immunol Lett 92:171-8. 2004..The concomitant expression of CXCR3 and CXCL10 in breast tumor cells suggests that a CXCR3-CXCL10 axis may function in these cells, and paves the way for an in depth analysis of CXCL10-CXCR3 interactions in breast tumor cells...
Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionGali Soria
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Sackler School of Medicine, Tel Aviv University, Israel
BMC Cancer 11:130. 2011..In this study, we wished to determine whether there are associations between these factors along stages of breast cancer progression, and to identify the possible implications of these factors to disease course...
Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptorLilach Goldberg-Bittman
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel
Cytokine 29:105-17. 2005....
Interleukin 8 and cell migration to inflammatory sites: the regulation of focal adhesion kinase under conditions of migratory desensitizationEfrat Cohen-Hillel
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel
Isr Med Assoc J 9:579-83. 2007..This over-phosphorylation of FAK was induced by IL-8 only when the receptor transmitting the chemokine signals was CXCR2 and not CXCR1, indicating that the two IL-8 receptors diverge in their signaling properties...
Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinasesEfrat Matityahu
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Eur J Immunol 32:3525-35. 2002..In all, CXCR1 and CXCR2 internalization and recycling are tightly regulated by receptor domains and by actin-related kinases...
Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cellsKarin Haim
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Neoplasia 13:230-43. 2011..The independent activities of EGF and estrogen on CXCL8 transcription reinforce the need to introduce simultaneous targeting of ErbBs and ERα to achieve effective therapy in breast cancer...
Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patientsRoni Mintz
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Immunol Lett 130:97-106. 2010....
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactionsGali Soria
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
Cytokine 44:191-200. 2008..These observations support a major tumor-promoting role for co-expression of the chemokines in breast malignancy, and agree with the significant association of joint RANTES and MCP-1 expression with advanced stages of breast cancer...
Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53David Sarid
Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Anticancer Res 28:3147-52. 2008..To correlate p53 and ErbB receptors status with disease-free survival (DFS) and overall survival (OS) in locally advanced breast cancer...
Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic markerMaya Golan
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Neoplasia 10:521-33. 2008..Furthermore, these results provide evidence for the possible involvement of endogenous retrovirus in human breast carcinoma...
Chemokines in human breast tumor cells: modifying their expression levels and determining their effects on the malignancy phenotypeGali Soria
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Methods Enzymol 460:3-16. 2009..In the breast malignancy context, the guidelines presented herein should enable researchers in the field to establish essential means for determination of chemokine roles in this disease...
The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cellsIdo Nevo
Department of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel
Immunol Lett 92:163-9. 2004..We hypothesize that these differences are due to an autocrine SDF-1alpha-CXCR4 axis...
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancyPravin Mishra
Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
J Leukoc Biol 89:31-9. 2011..The overall findings suggest that chemokines stand at the crossroads of tumor-CAF interactions that lead to increased malignancy in many cancer diseases...
The inflammatory chemokines CCL2 and CCL5 in breast cancerGali Soria
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
Cancer Lett 267:271-85. 2008....
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factorsElina Azenshtein
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel
Cancer Lett 217:73-86. 2005..These findings provide evidence for a complex set of pro-malignancy factors that may control the expression of angiogenic mediators at breast tumor sites...
Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sitesHila Attal
Department of Cell Research and Immunology, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
Exp Cell Res 314:352-65. 2008..Overall, we show that cross-talk between two GPCR is manifested by impairment of their intracellular trafficking, primarily of ligand-induced down-regulation, via carboxyl terminus phosphorylation sites...
Long-term survival of a patient with widespread metastases from epithelial ovarian carcinoma receiving mind-body therapies: case report and review of the literatureShahar Lev-Ari
Unit of Complementary Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Integr Cancer Ther 5:395-9. 2006..The authors review the relevant literature on this subject and describe what they believe to be the first report of long-term survival of such a patient...
Focal asymmetric breast density: mammographic, sonographic and pathological correlation in 97 lesions--a call to restrain biopsiesFani Sperber
Department of Radiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Isr Med Assoc J 9:720-3. 2007..The imaging parameters that mandate further diagnostic workup in focal asymmetric breast densities are not clearly defined...
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patientsNeora Yaal-Hahoshen
Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Clin Cancer Res 12:4474-80. 2006....
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II studyDavid Sarid
Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel
Clin Drug Investig 26:691-701. 2006..Clinical responses were not influenced by the initial tumour volume, and the only statistically significant predictor of pCR was the estrogen receptor status of the tumour...
Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancerFani Sperber
Breast Imaging Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Isr Med Assoc J 8:342-6. 2006..More exacting techniques of imaging combined with the classical methods are required...
Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factorsEran Neumark
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Int J Cancer 106:879-86. 2003..Our results also suggest that the expression of such factors is determined by several nonmutually exclusive regulatory mechanisms...
Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive diseaseNely Wigler
Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Isr Med Assoc J 4:940-3. 2002..The above results call for large-scale studies by numerous research groups to determine the prognostic value of RANTES expression...
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11Michal Dagan-Berger
Gene Therapy Institute, Hadassah University Hospital, PO Box 12000, Jerusalem, Israel
Blood 107:3821-31. 2006..Thus, distinct conformational changes induced by a given CXCR3 ligand trigger different downstream effectors of adhesion, motility, and CXCR3 desensitization...
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activityElina Azenshtein
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel
Cancer Res 62:1093-102. 2002....
